Welcome to our dedicated page for Steris news (Ticker: STE), a resource for investors and traders seeking the latest updates and insights on Steris stock.
STERIS plc provides healthcare and life sciences products and services that support patient care, with an emphasis on infection prevention. Its recurring news includes financial results and outlook updates for continuing operations, quarterly dividend actions, conference-call announcements, and board or executive governance changes.
The company’s business updates center on sterilization services, Applied Sterilization Technologies, sterilizers, washer-disinfectors, and decontamination equipment and supplies used by care providers and biopharma manufacturing sites. Corporate announcements also address capital spending, cash flow expectations, and shareholder distribution information.
An affiliate of Peak Rock Capital has completed the acquisition of HuFriedyGroup, the dental segment of STERIS plc (NYSE: STE). HuFriedyGroup, founded in 1908, is a global leader in dental instruments, infection prevention products, and instrument management systems. The company serves customers in approximately 100 countries and employs around 1,500 people across more than 20 global facilities. Peak Rock Capital sees this acquisition as a significant investment opportunity, aiming to drive new product innovation and organic growth. The firm also plans to support complementary acquisitions to expand the product and brand portfolio.
STERIS plc (NYSE: STE) announced financial results for its fiscal 2024 fourth quarter and full year, with total revenue up 12% to $5.5 billion. U.S. GAAP earnings per diluted share were $3.81, adjusted earnings per diluted share increased to $8.83. The company reported a targeted restructuring plan. Fourth quarter revenue increased 10% to $1.5 billion. Healthcare segment outperformed, with revenue growth primarily in the United States. Fiscal 2025 outlook includes mid-to-high single digit revenue growth and double-digit earnings growth.
STERIS plc (NYSE: STE) declared a quarterly interim dividend of $0.52 per share, payable on June 26, 2024. The Company focuses on infection prevention in healthcare and offers healthcare, life sciences, and dental products globally.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.